Want to see CPRX full AI Analyst Report?
Catalyst Pharma (CPRX) Ownership Overview
19.68% Mutual Funds
0.23% Other Institutional Investors
5.86% ETFs
74.22% Public Companies and Individual Investors
The ownership structure of Catalyst Pharma (CPRX) stock is a mix of institutional, retail, and individual investors. Approximately 25.78% of the company’s stock is owned by Institutional Investors, and 74.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 16, 2025 | xxxxxxxxxxxxx | $621778 | |
Nov 28, 2025 | xxxxxxxxxxxxx | $256233 | |
Sep 05, 2025 | xxxxxxxxxxxxx | $987200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $2079840 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $51746073 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $97643536 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $2034504 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,562,102 | Institution | 5.36% | 206,640,592 | |
| 4,999,363 | Institution | 4.08% | 157,429,941 | |
| 3,943,600 | Institution | 3.22% | 124,183,964 | |
| 2,089,906 | Institution | 1.71% | 65,811,140 | |
| 1,590,270 | Institution | 1.30% | 50,077,602 | |
| 1,311,486 | Institution | 1.07% | 41,298,694 | |
| 1,249,047 | Institution | 1.02% | 39,332,490 | |
| 1,165,650 | Institution | 0.95% | 36,706,319 | |
| 1,030,659 | Institution | 0.84% | 32,455,452 | |
| 764,699 | Institution | 0.62% | 24,080,372 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,999,363 | Institution | 4.08% | 157,429,941 | |
| 1,590,270 | Institution | 1.30% | 50,077,602 | |
| 1,311,486 | Institution | 1.07% | 41,298,694 | |
| 1,249,047 | Institution | 1.02% | 39,332,490 | |
| 1,165,650 | Institution | 0.95% | 36,706,319 | |
| 1,030,659 | Institution | 0.84% | 32,455,452 | |
| 764,699 | Institution | 0.62% | 24,080,372 | |
| 746,249 | Institution | 0.61% | 23,499,381 | |
| 742,200 | Institution | 0.61% | 23,371,878 | |
| 689,130 | Institution | 0.56% | 21,700,704 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,698,444 | Institution | 3.02% | 116,242,095 | |
| 1,317,914 | Institution | 1.08% | 41,422,037 | |
| 677,217 | Institution | 0.55% | 21,284,930 | |
| 402,286 | Institution | 0.33% | 12,643,849 | |
| 398,115 | Institution | 0.33% | 9,857,327 | |
| 330,752 | Institution | 0.27% | 10,395,535 | |
| 178,027 | Institution | 0.15% | 2,068,674 | |
| 125,937 | Institution | 0.10% | 3,958,200 | |
| 46,755 | Institution | 0.04% | 2,013,086 | |
| 24,211 | Institution | 0.02% | 757,347 |
FAQ
Who Owns Catalyst Pharmaceutical Partners (CPRX)?
Currently, no data Available
What percentage of Catalyst Pharmaceutical Partners (CPRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.23% of Catalyst Pharmaceutical Partners (CPRX) stock is held by institutional investors.
What percentage of Catalyst Pharmaceutical Partners (CPRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 74.22% of Catalyst Pharmaceutical Partners (CPRX) stock is held by retail investors.
Who owns the most shares of Catalyst Pharmaceutical Partners (CPRX)?
Vanguard owns the most shares of Catalyst Pharmaceutical Partners (CPRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.